Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro (0.3% Ciprofloxacin Otic Foam) Compared to Twice-Daily Dosing of Ciloxan (0.3% Ciprofloxacin Otic Solution) in Patients With Acute External Otitis.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2011
At a glance
- Drugs Ciprofloxacin (Primary) ; Ciprofloxacin
- Indications Bacterial infections; Otitis externa
- Focus Therapeutic Use
- 14 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2010 New trial record